A commentary notes that “with the clear identification of the heightened mortality risks in the first month of opioid substitution treatment that could be reduced substantially by persisting with treatment, easily implementable evidence based protocols and programs to treat opioid use disorder aggressively during this “golden month”—similar to those made against sepsis and medical errors—could well increase the number of lives saved by two specific opioids, methadone and buprenorphine.”